Beijing Kawin Technology Share-Holding Co., Ltd. (SHA:688687)

Market Cap	3.34B -24.3%
Revenue (ttm)	1.30B +3.8%
Net Income	11.06M -92.4%
EPS	0.07 -92.3%
Shares Out	167.44M
PE Ratio	298.51
Forward PE	16.15
Dividend	0.30 (1.46%)
Ex-Dividend Date	Jun 11, 2025

Volume	3,788,717
Average Volume	3,477,047
Open	20.56
Previous Close	20.56
Day's Range	19.95 - 20.56
52-Week Range	18.81 - 40.19
Beta	0.59
RSI	42.87
Earnings Date	Apr 25, 2026

About SHA:688687

Beijing Kawin Technology Share-Holding Co., Ltd., a biopharmaceutical company, provides treatment solutions for viral and immune diseases in China and internationally. The company offers recombinant human interferon alfa-2b injection; interferon alfa-2b vaginal effervescent tablets; coblopasvir hydrocholoride capsules; sofosbuvir tablets; peginterferon alfacon-2 injection; and compound glycyrrhizin tablets, capsules, and injections; and pirfenidone tablets for mild to moderate idiopathic pulmonary fibrosis. It is also involved in contract manuf...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 600
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688687

Financial Performance

In 2025, SHA:688687's revenue was 1.32 billion, an increase of 7.35% compared to the previous year's 1.23 billion. Earnings were 30.60 million, a decrease of -78.51%.